Test Directory

Home Test Search Results Beta-2 Glycoprotein I Antibody (IgG, IgM, IgA)
Beta-2 Glycoprotein I Antibody (IgG, IgM, IgA)

Justification

Beta-2 Glycoprotein I (B2GPI) antibodies are associated with antiphospholipid syndrome (APS). Persistently elevated levels of B2GPI antibodies are associated with an increased risk of vascular thrombosis and obstetrical complications.

STAT: < 48 hours (M-F)

CIA

Draw Tube: Red Top

Sample Type: Serum

Specimen Requirements

Sample Type Volume Required Minimum Volume Stability
PREFERRED Serum 1mL 0.5mL Room Temp.: 7 days
Refrigerated: 14 days
Frozen (-20C): 1 month
Frozen (-80C): 6 months
ALTERNATIVE Citrated Plasma 1mL - Frozen (-20C): 1 month
Frozen (-80C): 6 months
REJECTION CRITERIA Thawed in transit, refrozen or clotted sample
SPECIAL INSTRUCTIONS -

General Information

METHODOLOGY CIA
STAT TAT < 48 hours (M-F)
STAT TAT Performance > 90% of results released in 48 hours
ROUTINE TAT < 3 days (M-F)
ALTERNATIVE NAMES B2GPI, B2GP1
DESCRIPTION This assay employs an FDA-approved, chemiluminescent immunoassay (CIA) method and reports in arbitrary chemiluminescent units (CU).
LIMITATIONS -
NORMAL RANGE < 20 CU
ASSOCIATED TESTING -
REFERENCES -
SAMPLE REPORT Upon request
NEW YORK STATE APPROVED -

Test Codes

ORDER CODE P3311
CPT CODE 86146x3
LOINC CODE 16135-6, 21108-6, 16136-4